Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters

Nucleic Acids Research

Volumn 40, Issue 16, 2012, Pages 7776-7787

  Barros, Patrícia ^a,b   Lam, Eric W F ^c   Jordan, Peter ^a,b   Matos, Paulo ^a,b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 2B; P21 ACTIVATED KINASE 1; PROTEIN BCL 6; RAC1 PROTEIN; STAT5A PROTEIN; SUMO 1 PROTEIN;

ARTICLE; CELL CYCLE REGULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYCLIN D2 GENE; CYCLIN DEPENDENT KINASE INHIBITOR 2B GENE; ENZYME ACTIVATION; GENE CONTROL; GENE IDENTIFICATION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REPORTER GENE; SIGNAL TRANSDUCTION; SMALL UBIQUITIN LIKE MODIFIER 1 GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-6; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84870572352     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks571     Document Type: Article

References (47)

1. Plotnikov, A., Zehorai, E., Procaccia, S. and Seger, R. (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim. Biophys. Acta, 1813, 1619-1633.
2. Horvath, C.M. (2000) STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci., 25, 496-502.
3. Hall, A. (1998) Rho GTPases and the actin cytoskeleton. Science, 279, 509-513.
4. Benitah, S.A., Valeron, P.F., van Aelst, L., Marshall, C.J. and Lacal, J.C. (2004) Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim. Biophys. Acta, 1705, 121-132.
5. Boyer, L., Travaglione, S., Falzano, L., Gauthier, N.C., Popoff, M.R., Lemichez, E., Fiorentini, C. and Fabbri, A. (2004) Rac GTPase instructs nuclear factor-iB activation by conveying the SCF complex and IkBa to the ruffling membranes. Mol. Biol. Cell, 15, 1124-1133.
6. Matos, P. and Jordan, P. (2006) RAC1, but not RAC1B, stimulates RELB-mediated gene transcription in colorectal cancer cells. J. Biol. Chem., 281, 13724-13732.
7. Simon, A.R., Vikis, H.G., Stewart, S., Fanburg, B.L., Cochran, B.H. and Guan, K. (2000) Regulation of STAT3 by direct binding to the Rac1 GTPase. Science, 290, 144-147.
8. Tonozuka, Y., Minoshima, Y., Bao, Y.C., Moon, Y., Tsubono, Y., Hatori, T., Nakajima, H., Nosaka, T., Kawashima, T. and Kitamura, T.A. (2004) GTPase-activating protein binds STAT3 and is required for IL-6-induced STAT3 activation and for differentiation of a leukemic cell line. Blood, 104, 3550-3557.
9. Kawashima, T., Bao, Y.C., Nomura, Y., Moon, Y., Tonozuka, Y., Minoshima, Y., Hatori, T., Tsuchiya, A., Kiyono, M., Nosaka, T. et al. (2006) Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J. Cell Biol., 175, 937-946.
10. Barros, P., Jordan, P. and Matos, P. (2009) Rac1 signaling modulates BCL-6-mediated repression of gene transcription. Mol. Cell. Biol., 29, 4156-4166.
11. Seyfert, V.L., Allman, D., He, Y. and Staudt, L.M. (1996) Transcriptional repression by the proto-oncogene BCL-6. Oncogene, 12, 2331-2342.
12. Staudt, L.M., Dent, A.L., Shaffer, A.L. and Yu, X. (1999) Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. Rev. Immunol., 18, 381-403.
13. Dent, A.L., Vasanwala, F.H. and Toney, L.M. (2002) Regulation of gene expression by the proto-oncogene BCL-6. Crit. Rev. Oncol. Hematol., 41, 1-9.
14. Bajalica-Lagercrantz, S., Piehl, F., Farnebo, F., Larsson, C. and Lagercrantz, J. (1998) Expression of the BCL6 gene in the preand postnatal mouse. Biochem. Biophys. Res. Commun., 247, 357-360.
15. Lin, Z., Kim, H., Park, H., Kim, Y., Cheon, J. and Kim, I. (2003) The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium. Urol. Res., 31, 272-275.
16. Huang, Y.C., Hung, W.C., Kang, W.Y., Chen, W.T. and Chai, C.Y. (2007) Expression of STAT3 and Bcl-6 oncoprotein in sodium arsenite-treated SV-40 immortalized human uroepithelial cells. Toxicol. Lett., 173, 57-65.
17. Otaki, J.M., Fearon, D.T. and Yamamoto, H. (2005) The proto-oncogene BCL-6 is expressed in olfactory sensory neurons. Neurosci. Res., 53, 189-200.
18. Kanazawa, N., Moriyama, M., Onizuka, T., Sugawara, K. and Mori, S. (1997) Expression of bcl-6 protein in normal skin and epidermal neoplasms. Pathol. Int., 47, 600-607.
19. Logarajah, S., Hunter, P., Kraman, M., Steele, D., Lakhani, S., Bobrow, L., Venkitaraman, A. and Wagner, S. (2003) BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene, 22, 5572-5578.
20. Allman, D., Jain, A., Dent, A., Maile, R.R., Selvaggi, T., Kehry, M.R. and Staudt, L.M. (1996) BCL-6 expression during B-cell activation. Blood, 87, 5257-5268.
21. Chang, C.C., Ye, B.H., Chaganti, R.S. and Dalla-Favera, R. (1996) BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. U.S.A., 93, 6947-6952.
22. Huynh, K.D., Fischle, W., Verdin, E. and Bardwell, V.J. (2000) BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev., 14, 1810-1823.
23. Dalla-Favera, R., Migliazza, A., Chang, C.C., Niu, H., Pasqualucci, L., Butler, M., Shen, Q. and Cattoretti, G. (1999) Molecular pathogenesis of B cell malignancy: the role of BCL-6. Curr. Top. Microbiol. Immunol., 246, 257-263.
24. Niu, H. (2002) The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol. Oncol., 20, 155-166.
25. Shaffer, A.L., Yu, X., He, Y., Boldrick, J., Chan, E.P. and Staudt, L.M. (2000) BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity, 13, 199-212.
26. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D. and Staudt, L.M. (1997) Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science, 276, 589-592.
27. Matos, P., Collard, J. and Jordan, P. (2003) Tumour-related alternative-spliced Rac1b is not regulated by Rho-GDI and exhibits selective downstream signalling. J. Biol. Chem., 278, 50442-50448.
28. Matos, P., Oliveira, C., Velho, S., Gonçalves, V., da Costa, L.T., Moyer, M.P., Seruca, R. and Jordan, P. (2008) B-RafV600E cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterology, 135, 899-906.
29. Fernández de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A.M., Birkenkamp, K.U., Edwards, C.S., Martino, A., Nelson, B.H., Francis, J.M., Jones, M.C. et al. (2004) FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol. Cell. Biol., 24, 10058-10071.
30. Solan, N.J., Miyoshi, H., Carmona, E.M., Bren, G.D. and Paya, C.V. (2002) RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem., 277, 1405-1418.
31. Tang, T.T., Dowbenko, D., Jackson, A., Toney, L., Lewin, D.A., Dent, A.L. and Lasky, L.A. (2002) The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J. Biol. Chem., 277, 14255-14265.
32. Meyer, R.D., Laz, E.V., Su, T. and Waxman, D.J. (2009) Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5. Mol. Endocrinol., 23, 1914-1926.
33. Tran, T.H., Utama, F.E., Lin, J., Yang, N., Sjolund, A.B., Ryder, A., Johnson, K.J., Neilson, L.M., Liu, C., Brill, K.L. et al. (2010) Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Res., 70, 1711-1721.
34. Calò, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N. and Russo, A. (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell Physiol., 197, 157-168.
35. Li, H., Zhang, Y., Glass, A., Zellweger, T., Gehan, E., Bubendorf, L., Gelmann, E.P. and Nevalainen, M.T. (2005) Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence. Clin. Cancer Res., 11, 5863-5868.
36. Xiong, H., Su, W.Y., Liang, Q.C., Zhang, Z.G., Chen, H.M., Du, W., Chen, Y.X. and Fang, J.Y. (2009) Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells. Lab. Invest., 89, 717-725.
37. Pelletier, S., Duhamel, F., Coulombe, P., Popoff, M.R. and Meloche, S. (2003) Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol. Cell. Biol., 23, 1316-1333.
38. Bouchard, C., Thieke, K., Maier, A., Saffrich, R., Hanley-Hyde, J., Ansorge, W., Reed, S., Sicinski, P., Bartek, J. and Eilers, M. (1999) Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J., 18, 5321-5333.
39. Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Möröy, T., Bartek, J., Massagué, J., Hänel, F. et al. (2001) Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell Biol., 3, 392-399.
40. Mermelshtein, A., Gerson, A., Walfisch, S., Delgado, B., Shechter-Maor, G., Delgado, J., Fich, A. and Gheber, L. (2005) Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br. J. Cancer, 93, 338-345.
41. Liu, Y., Yang, Y., Xu, H. and Dong, X. (2010) Implication of USP22 in the regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and cyclin D2 expression in primary colorectal carcinomas. Diagn. Mol. Pathol., 19, 194-200.
42. Gareau, J.R. and Lima, C.D. (2010) The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell. Biol., 11, 861-871.
43. Zhang, Z., Rosen, D.G., Yao, J.L., Huang, J. and Liu, J. (2006) Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. Mod. Pathol., 19, 1339-1343.
44. Walker, S.R., Nelson, E.A. and Frank, D.A. (2007) STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene, 26, 224-233.
45. Luo, G. and Yu-Lee, L. (1997) Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters. J. Biol. Chem., 272, 26841-26849.
46. Nelson, E.A., Walker, S.R., Alvarez, J.V. and Frank, D.A. (2004) Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J. Biol. Chem., 279, 54724-54730.
47. Sahai, E. and Marshall, C.J. (2002) Rho-GTPases and cancer. Nat. Rev. Cancer, 2, 133-142.